Results

Total Results: 892 records

Showing results for "end stage renal".

721. Timeliness of Antibiotic Prophylaxis for Children With Sickle Cell Disease (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-135-fullreport.pdf
     February 01, 2017 - including pain episodes, sepsis, stroke, acute chest syndrome, priapism, leg ulcers, osteonecrosis, and renal

722. Hypertension-Pulmonary-Arterial Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
     April 01, 2013 - disease, thyroid disorders 5.4 Others: tumoral obstruction, fibrosing mediastinitis, chronic renal … Limited data suggest that epoprostenol and bosentan may provide a survival benefit; however, this end … At the full- text screening stage, two independent reviewers read each article to determine if it met … Of these, 1,127 were excluded at the full-text screening stage, leaving 197 articles (representing … – Consider studies of additional promising measures such as end diastolic pulmonary regurgitation

723. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
     January 01, 2016 - ITCA 650 pump system compared with twice-daily exenatide injections (Ex-BID) was evaluated in a two-stage … Stage II (n=131) re-randomly assigned patients to receive 20, 40, 60, or 80 mcg/day of ITCA 650 for … Stage I: mean change in HbA1c from a mean baseline of 7.9-8.0% was -0.98, -0.95, and -0.72% for the … Stage II: significant (P < 0.05) reductions in HbA1c (∼1.4% from baseline) were achieved with 60 and … This would require more patient followup to monitor renal function.

724. Nis 2010 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2010_MaskedStats_Severity.PDF
     January 01, 2010 - Pulmonary circulation disorders 7,800,441 0 0.00 1.00 0.02 0.12 CM_RENLFAIL : AHRQ comorbidity measure: Renal … comorbidity measure: Weight loss 7,800,441 0 0.00 1.00 0.03 0.18 DS_Stage1 : Disease Staging: Principal Stage … malignancy 9,350 0.12% 443: Kidney & urinary tract procedures for nonmalignancy 15,434 0.20% 444: Renal … 0.10% GUS06: Neoplasm, Malignant: Kidneys 11,629 0.15% GUS07: Nephrotic Syndrome 1,268 0.02% GUS08: Renal … 0.01% MUS13: Fracture: Radial Shaft, Ulna or Olecranon 4,243 0.05% MUS14: Fracture: Radius, Lower End

725. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
     January 01, 2016 - evaluated in a randomized phase II trial in patients with T2DM inadequately controlled with metformin.47 Stage … For Stage II, 131 subjects were re-randomly assigned to receive 20, 40, 60, or 80 mcg/day of ITCA 650 … Stage I: mean change in HbA1c from a mean baseline of 7.9-8.0% was -0.98, -0.95, and -0.72% for the … Stage II: significant 9 (P < 0.05) reductions in HbA1c (∼1.4% from baseline) were achieved with … This expert added that prescribing providers would need to be willing to monitor renal function in

726. e3iVR: Conference on Ethics in Investigational and Interventional Uses of Immersive VR - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/citation/r13hs024833-gill-final-report-2017.pdf
     January 01, 2017 - Results: By the end of Day 2, the group of stakeholder representatives and subject matter experts produced … These talks set the stage for development of guidelines that address the needs of these priority populations … reality include but are not limited to (i) the training of health professionals (e.g., percutaneous renal … If recognition of biases and defective perceptions in VR does not occur, we could end up increasing

727. Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
     January 15, 2015 - • Harms, risks and consequences of testing o Procedural harms, adverse events of testing (e.g., renal … Harms, risks and consequences of testing (both initial and subsequent testing) • Harms of testing (renal … Thus, to set the stage for the review’s Key Questions, which are focused on clinical decisionmaking … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

728. Archived: Final Evidence Review: Hepatitis C: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review49/hepatitis-c-screening-2013
     November 15, 2012 - Clinical outcomes were mortality, end-stage liver disease, cirrhosis, hepatocellular carcinoma, need … Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis … Liver histology in renal transplant patients after more than 10 years of hepatitis C virus infection.

729. Standards and Regulatory Frameworks Workgroup: Prioritizing Patient Preferences for Standardization to Support PC CDS (pdf file)
     cdsic.ahrq.gov/sites/default/files/2024-09/SRF_Patient%20Preference%20Standardization%20Priorities_508.pdf
     January 01, 2024 - of, ‘I’m asking you, patient, what would you want in this scenario for advanced care planning or end … As an example, a patient with end-stage renal disease may initially indicate a preference for dialysis … Advance Care Directives • Cardiopulmonary resuscitation • Intubation and ventilation End-of-life … care • End-stage treatment • Alignment with family preferences • Location (location of death)

730. Standards and Regulatory Frameworks Workgroup: Prioritizing Patient Preferences for Standardization to Support PC CDS (pdf file)
     digital.ahrq.gov/sites/default/files/SRF_Patient%20Preference%20Standardization%20Priorities_508.pdf
     August 01, 2024 - of, ‘I’m asking you, patient, what would you want in this scenario for advanced care planning or end … As an example, a patient with end-stage renal disease may initially indicate a preference for dialysis … Advance Care Directives • Cardiopulmonary resuscitation • Intubation and ventilation End-of-life … care • End-stage treatment • Alignment with family preferences • Location (location of death)

731. Adverse Events Among In-Hospital Medicare Patients in 2021 and 2022 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/quality-measures/qsrs/qsrs-2021-2023-adverse-event-data-report.pdf
     January 01, 2023 - In 2020, the MPSMS reached the end of its service life and was replaced by the QSRS. B. … IHS cohort.xv For the hospital cohorts included in this report, CMS implemented a stratified, two-stage … injuries observed in the OIG report, but the OIG report only considered severe pressure injuries (Stage … 3, Stage 4, and unstageable) and used data from an unweighted sample from October 2018. … Other Other occurrences Renal failure Unplanned transfer Ventilator support (non-OR) 8.

732. Collaborative Modeling of U.S. Breast Cancer Screening Strategies (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/nmcMhEwWT9BncBBBQQN6Uf
     December 01, 2015 - years, with exponential distribution using DCIS incidence data from the Surveillance, Epidemiology and End … On the other end of the spectrum, the model allows for another subset of tumors to be “aggressive” by … years to capture lifetime reductions in breast cancer mortality occurring years after the start (and end … Surveillance, Epidemiology and End Results Program (SEER): SEER*Stat Software. … )vascular disease; paralysis; diabetes 12% 13 Severe AIDS; mild or severe liver disease; chronic renal

733. Collaborative Modeling of U.S. Breast Cancer Screening Strategies (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFile/1/16255/collabmodelingbc/pdf
     December 01, 2015 - years, with exponential distribution using DCIS incidence data from the Surveillance, Epidemiology and End … On the other end of the spectrum, the model allows for another subset of tumors to be “aggressive” by … years to capture lifetime reductions in breast cancer mortality occurring years after the start (and end … Surveillance, Epidemiology and End Results Program (SEER): SEER*Stat Software. … )vascular disease; paralysis; diabetes 12% 13 Severe AIDS; mild or severe liver disease; chronic renal

734. In Conversation With… Sharon K. Inouye, MD, MPH | PSNet
     psnet.ahrq.gov/perspective/conversation-sharon-k-inouye-md-mph
     December 01, 2012 - tried to get them to share what they were using with me because I really viewed that as a means to an end … delirium, some of them say things like delirium following alcohol withdrawal, or delirium following renal … They're a little hyponatremic, going into renal failure, and on medications that maybe the doctor has … brain function [ 5 ]), it is worth thinking about delirium as an "acute brain injury" similar to other end-organ … As with these other important end-organ injuries, delirium is a clinical event for which prevention and

735. Linking Dental Services to Treatment Outcomes for Diabetes: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
     November 01, 2024 - The program has begun to develop a range of rapid evidence products to assist end users in making specific … risk of all-cause mortality, highlighting the impact of oral health on cardiovascular, immune, and renal … Summarized are the details for each study regarding study location, funding source, DM stage, quality … , Outcomes Detail 13 Author, Year; Country; Funding Source; DM Stage; Quality Design; … Summarized are the details for each study regarding study location, funding source, DM stage, quality

736. Clinical Decision Support Systems: State of the Art (pdf file)
     digital.ahrq.gov/sites/default/files/docs/page/09-0069-EF_1.pdf
     June 01, 2009 - remembered, though, that these health IT applications are a means to improve health care quality, not an end … CDS can include nationally recommended guidelines at one end of the continuum and customized order sets … development and initial implementation costs for a CDS targeted to medication prescribing for adults with renal … Computerized clinical decision support during medication ordering for long-term care residents with renal … implementing a computerized clinical decision support system for medication dosing for patients with renal

737. Enhancing self-management of T2DM with an Automated Reminder and Feedback System (pdf file)
     digital.ahrq.gov/sites/default/files/docs/publication/r18hs017276-burns-final-report-2011.pdf
     January 01, 2011 - Specific aims and hypotheses of the study were to: To this end we developed and refined an Automated … therapy for solid tumors (except hormonal therapy for prostate cancer); hospice enrollment; cirrhosis; end-stage … renal disease; two or more admissions for congestive heart failure within 6 months; and lung disease … At the end of the trial, participants in the IG group were also asked about their satisfaction with … associated with baseline glycemic levels, the number of participants may have been too small by the end

738. FRN 29: Future Research Needs on Procalcitonin-Guided Antibiotic Therapy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
     August 01, 2014 - Changes in outcomes from the beginning to the end of the study are compared across groups. … To that end, stratification may be needed to assess the contribution of procalcitonin in populations … Changes in outcomes from the beginning to the end of the study are compared across groups. … For patients with underlying stable chronic disease (e.g. diabetes, renal disease, but excluding immunocompromised … diabetes, renal disease, but excluding immunocompromised patients) and a high uncertainty of infection

739. Cad-Women-Diagnosis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
     June 01, 2012 - contrast agent used during the procedure to visualize the coronary arteries may cause anaphylaxis, renal … During the topic refinement stage, we solicited input from Key Informants, representing clinicians ( … At the full-text screening stage, two independent reviewers read each article to determine if it met … At the full-text review stage, paired researchers independently reviewed the articles and indicated … Of these, 1,662 articles were excluded at the full-text screening stage.

740. The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/pnyU5fxhdBUtCdvJ3GyqzR
     March 01, 2007 - Ann Intern Med. 2007;146:365-375. www.annals.org For author affiliations, see end of text. … In addition, cases of cancer detected by screening may be in the early stage and therefore cur- able. … We sought studies on gastrointestinal, cardiovascular, and renal harms associated with the aspirin use … Study selection, inclusion, and exclusion at each screening phase for the efficacy end points. … Regular use of aspirin or other NSAIDs; history of myocardial infarction, stroke, cancer, liver or renal